Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Zeo ScientifiX, Inc.BPSR · Entity 8005 | Director | March 08, 2017 | April 06, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Zeo ScientifiX, Inc.
Report date March 08, 2017 · Filed April 06, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Warrant (right to purchase)SEC Table II · derivative / convertible security · Conversion / exercise price $0.15 · Expires 2020-02-28 | Direct | 150,000 |
Reported balance
After 2017-02-28 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2017-02-28 · Grant · Acquired 150,000 · Balance 150,000 F1: Issued in connection with that certain Participation Agreement, effective February 14, 2017, between the Issuer and Reporting Person. |
Filing footnotes · ownership attribution and instrument terms
F1: Issued in connection with that certain Participation Agreement, effective February 14, 2017, between the Issuer and Reporting Person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 28, 2017 Filed Apr 6, 2017 22:50 UTC | Zeo ScientifiX, Inc. BPSR · Entity 8005 | GrantWarrant (right to purchase) · Derivative | 150,000 | $0.00 Strike: $0.15 | $0.00 |
DisclosureSEC source: 0001703129-17-000001 · primary_doc.xml · derivative · entry 1 TADDEO PETER · CIK 0001703129 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2020-02-28 F1 · price: Issued in connection with that certain Participation Agreement, effective February 14, 2017, between the Issuer and Reporting Person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.